Hospital Center Effect for Laparoscopic Colectomy Among Elderly Stage I-III Colon Cancer Patients

被引:17
|
作者
Zheng, Zhiyuan [1 ]
Hanna, Nader [2 ]
Onukwugha, Eberechukwu [1 ]
Bikov, Kaloyan A. [1 ]
Mullins, C. Daniel [1 ]
机构
[1] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Sch Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Surg, Div Gen & Oncol Surg, Baltimore, MD 21201 USA
关键词
hospital center effect; laparoscopic colectomy; colon cancer; length of stay; in-hospital mortality; 30-day rehospitalization; multilevel regression; SEER-Medicare; BREAST-CANCER; OPEN SURGERY; CARE;
D O I
10.1097/SLA.0b013e31829d0468
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To investigate hospital-level variation in short-term laparoscopic colectomy outcomes among stage I-III elderly colon cancer patients. Background: Surgical outcomes are associated with patient and surgeon characteristics. If outcomes are also impacted by the hospital where the surgery occurs, there is a hospital center effect (HCE). Methods: Surveillance, Epidemiology, and End Results (SEER)-Medicare data was used to identify stage I-III colon cancer patients treated with laparoscopic colectomies. Multilevel regressions were utilized to study potential HCE for length of stay (LOS), 30-day rehospitalization, and in-hospital mortality, adjusting for patient, surgeon, and hospital-level characteristics. To quantify HCE, we calculated the median instantaneous rate ratio (MIRR) for LOS and median odds ratio (MOR) for in-hospital mortality and 30-day rehospitalization. Sensitivity analyses were conducted for high volume/medical school affiliated hospitals and colorectal surgeons. Results: The multilevel analyses based on 4617 patients from 465 hospitals documented statistically significant HCEs for LOS (MIRR = 1.35; P < 0.001) and in-hospital mortality (MOR = 1.69; P = 0.032), but no HCE for 30-day rehospitalization. Sensitivity analyses confirmed our findings. HCE was significant for LOS in all sensitivity analyses and was significant for in-hospital mortality for high volume/medical school affiliated hospitals. Conclusions: HCE exists for LOS and in-hospital mortality of laparoscopic colectomy, which suggests that the choice of hospital affects outcomes independently of other confounding variables. Reducing the variation in outcomes associated with HCE may improve the quality of cancer care.
引用
收藏
页码:924 / 929
页数:6
相关论文
共 50 条
  • [41] Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
    Zuckerman, Ilene H.
    Rapp, Thomas
    Onukwugha, Ebere
    Davidoff, Amy
    Choti, Michael A.
    Gardner, James
    Seal, Brian
    Mullins, C. Daniel
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (08) : 1403 - 1410
  • [42] Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients
    Lino-Silva, Leonardo S.
    Anchondo-Nunez, Patricia
    Chit-Huerta, Alonso
    Aguilar-Romero, Estefania
    Morales-Soto, Jonathan
    Salazar-Garcia, Jenny A.
    Guzman-Lopez, Cristina J.
    Maldonado-Martinez, Hector A.
    Meneses-Garcia, Abelardo
    Salcedo-Hernandez, Rosa A.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 300 - 307
  • [43] Laparoscopic versus open colectomy for TNM stage III colon cancer: results of a prospective multicenter study in Italy
    Mario Guerrieri
    Roberto Campagnacci
    Angelo De Sanctis
    Giovanni Lezoche
    Paolo Massucco
    Massimo Summa
    Rosaria Gesuita
    Lorenzo Capussotti
    Giuseppe Spinoglio
    Emanuele Lezoche
    Surgery Today, 2012, 42 : 1071 - 1077
  • [44] Race, Oxaliplatin Use, and Treatment Outcomes for Stage III Colon Cancer among Elderly Medicare Patients
    Mack, Christina D.
    Carpenter, William
    Sturmer, Til
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S128 - S128
  • [45] Grade III-IV toxicities among elderly stage III colon cancer patients receiving CAPOX or capecitabine
    van Erning, F.
    Janssen-Heijnen, M.
    Creemers, G. -J.
    Pruijt, H.
    Lemmens, V.
    ANNALS OF ONCOLOGY, 2015, 26
  • [46] Impact of Smoking on Stage I-III Gastric Cancer: A Single-Center Retrospective Study
    Singh, Samrath
    Eng, Kevin
    Singh, Amanpal
    Reid, Mary
    Malhotra, Usha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S55 - S56
  • [47] Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension
    Dey, HM
    Soufer, R
    Hoffer, P
    Wackers, FJT
    Black, HR
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (06) : 598 - 606
  • [48] Laparoscopic versus open colectomy for TNM stage III colon cancer: results of a prospective multicenter study in Italy
    Guerrieri, Mario
    Campagnacci, Roberto
    De Sanctis, Angelo
    Lezoche, Giovanni
    Massucco, Paolo
    Summa, Massimo
    Gesuita, Rosaria
    Capussotti, Lorenzo
    Spinoglio, Giuseppe
    Lezoche, Emanuele
    SURGERY TODAY, 2012, 42 (11) : 1071 - 1077
  • [49] MICROPAPILLARY PATTERN IS AN INDEPENDENT PREDICTOR FOR POOR ONCOLOGIC OUTCOME IN STAGE I-III COLON CANCER.
    Pyo, D.
    Cho, Y.
    Lee, W.
    Yun, S.
    Kim, H.
    Huh, J.
    Park, Y.
    Shin, J.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E154 - E155
  • [50] Efficacy and Toxicity of Adjuvant FOLFOX Chemotherapy in Elderly Patients With Stage III Colon Cancer - Single Center Study
    Kim, J. Y.
    Kim, Y. J.
    Lee, K. W.
    Kim, D. W.
    Lee, H. S.
    Kim, J. S.
    Kang, S. B.
    Lee, J. S.
    Kim, J. H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S279 - S279